India's Himachal High Court Panel Urges Lower Drug Prices For Poor
This article was originally published in PharmAsia News
Executive Summary
A panel of the Himachal High Court of India challenged the pharmaceutical industry to sell its products at a "reasonable" profit, saying the control of prices of health care could lead to more and better facilities for the nation's poor.